Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire de Nīmes
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with metastatic prostate cancer treated with enzalutamide or abiraterone acetate for at least 3 months
The patient must have given their free and informed consent and signed the consent form
The patient must be insured or the beneficiary of an insurance policy
You may not be if
The subject is not in a fit state to express their consent
It is impossible to give the subject informed information
The patient is under safeguard of justice or state guardianship
Clareo Health | Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy
